Legacy MEDSearch

OCTOBER 30, 2023

Medinol today announced United States Food and Drug Administration (FDA) approval for the EluNIR-PERL drug-eluting stent (DES) for the treatment of coronary artery disease. EluNIR-PERL builds upon the proven performance and clinical data of the EluNIR DES system. “We are pleased to bring technologies to the U.S.

Food and Drug Administration 52

Food and Drug Administration FDA Distribution Recruitment 52

Legacy MEDSearch

SEPTEMBER 5, 2023

a medical software innovator dedicated to enhancing clinical impact in ablation therapy, announced today that it has received 510(k) clearance from the USA Food and Drug Administration (FDA) for its VisAble.IO solution is not yet approved for sale or distribution in the USA and is limited by USA law to investigational use.

FDA 52

FDA Food and Drug Administration Physicians Recruitment 52

Pharma Marketing Network

JULY 10, 2023

This type of advertising is often used to raise awareness of a new drug or to promote a new indication for an existing drug. Direct-to-physician (DTP) advertising: DTP advertising is advertising that is directed to healthcare providers.

Healthcare 40

Healthcare Healthcare Marketing Pharma 40

Legacy MEDSearch

APRIL 12, 2023

These new FDA clearances follow the highly successful clinical introduction of MONTAGE use on bleeding bone, which has garnered excellent physician feedback and surpassed 22,000 product uses with thousands of patients now multiple years removed from surgery.

FDA 52

FDA Food and Drug Administration Recruitment Manufacturing 52

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. The list, designed to serve as a reference point for prioritized drug review and evaluation policies, included 121 rare diseases. [8]. 10] [11] [12].

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Evolve Your Success

MAY 17, 2022

You know when they are trying to push a drug and white-knuckling it. When a physician decides to use a robotic machine, that is not part of my decision-making process and the OR manager. You ask the hospital administrators to figure out the financial aspects of that side of it. What drugs are we using? Sales can be pushy.

Medical sales 52

Medical sales Medical Sales Patients 52

Pharmaceutical Technology

JUNE 30, 2022

Another factor driving Georgia’s growth in the clinical trial space is the recent significant investment in the country’s health system, creating several new facilities and programmes, as well as increasing the number of experienced physicians. Expert partners.

Food and Drug Administration 52

Food and Drug Administration Distribution Recruitment Transportation 52